Liposomal Semaglutide Could Be the Next Big Leap in GLP-1 Drug Delivery Kathrin Hielscher , published in Hielscher News GLP-1 peptides such as semaglutide has become one of the most influential peptide therapeutics of the last decade, with broad clinical use in type 2 diabetes and obesity
2008;13(2):1657 Back M, Yin L, Ingelsson E
H3K4 methylation regulates LPS-induced proinflammatory cytokine expression and release in macrophages
How to take it: Tablets, swallow with water, after food Sublingual tablets, place under the tongue, let it dissolve Injection, given by a doctor or nurse, usually in muscle (intramuscular) Never self-inject without proper medical guidance When to take it: Morning is generally preferred Taking it with food helps reduce any mild nausea Try to take it at the same time every day for consistency Dosage guidelines (general reference): Mild deficiency, 500 to 1000 mcg orally per day Severe deficiency, 1000 to 1500 mcg via injection, daily or alternate days initially Maintenance dose, 1000 mcg monthly injection in many cases What Research Says: According to NIH clinical data, initial treatment for severe B12 deficiency often involves daily injections for 1-2 weeks, followed by weekly, then monthly doses
J Clin Oncol:JCO2018789032
